Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec
Top Cited Papers
Open Access
- 1 November 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (9), 1254-1260
- https://doi.org/10.1086/496986
Abstract
Background. Since 2002, an epidemic of Clostridium difficile–associated-diarrhea (CDAD) associated with a high case-fatality rate has involved >30Keywords
This publication has 40 references indexed in Scilit:
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospitalInternational Journal of Antimicrobial Agents, 2004
- C. difficile: by the numbersCMAJ : Canadian Medical Association Journal, 2004
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- The Incidence of Clostridium difficile--Associated and Non--C. difficile--Associated Diarrhea after Use of Gatifloxacin and Levofloxacin in an Acute-Care FacilityClinical Infectious Diseases, 2004
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999
- Epidemiology, Risk Factors and Treatments for Antibiotic-Associated DiarrheaDigestive Diseases, 1998
- Immune response to Clostridium difficile infectionEuropean Journal of Gastroenterology & Hepatology, 1996
- Clostridium Difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994